IVD Raw Materials Market - Global Outlook & Forecast 2022-2027

With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share.

The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased the speed and ease of using the devices the workforce is thoroughly trained and adopted. Furthermore, the global IVD raw materials market is expected to witness an incremental growth of USD 9.91 billion and absolute growth of 40.73% by 2027.

The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period:

• Increasing Prevalence of Infectious & Chronic Diseases
• Growing Awareness for Early Diagnosis and Disease Prevention
• Surge In Demand for IVD Testing & Devices
• Rise In Availability of Advanced Home Care Kits for Cancer Diagnostics

KEY HIGHLIGHTS

• Growing trends for point of care diagnostics and personalized medicine contribute to the growth of the IVD raw materials market.
• Investment in the development and commercial launch of IVD instruments and rapid test kits to diagnose several infectious diseases and their applications in the research segment will boost the market in developed countries.
• In 2021, pharma & biotech companies accounted for the major share of 62.19% in the global IVD raw materials market. However, diagnostic laboratories are likely to witness the highest absolute growth of 43.37% during the forecast period.
• Vendors offer a broad portfolio of quality enzymes that are highly suitable for manufacturing diagnostic kits and reagents. Manufacturers are also exploring new enzyme sources from enormous enzymes and optimizing and transforming the most appropriate enzyme molecules.

THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:

• Product
• Technology
• End-User
• Geography

SEGMENTATION ANALYSIS

Rapid tests developed through clinical chemistry provides test results immediately. Manufacturers offer many IVD raw materials applicable to clinical chemistry methods. The global IVD raw materials market by clinical chemistry is expected to reach USD 12.14 billion by 2027. Furthermore, private laboratories have expanded their footprints in recent years, especially in developing countries, which has stimulated market growth. Moreover, the demand for standalone reference laboratories is gradually rising due to the prevalence of epidemic and pandemic conditions across the globe. The global IVD raw materials market by diagnostic laboratories will grow at a CAGR of over 6% during 2022-2027.

• Segmentation Analysis by Product
• Antibody & Antigen
• Enzymes
• Proteins
• Biological Buffers
• Others
• Segmentation Analysis by Technology
• Clinical Chemistry
• Immunochemistry
• Molecular Diagnostics
• Others
• Segmentation Analysis by End-User
• Pharma & Biotech Companies
• Diagnostic Laboratories
• Others

COMPETITIVE LANDSCAPE

Major manufacturers of IVD raw materials are focusing on their proprietary processing techniques that satisfy the raw material requirements of the IVD industry and provide IVD raw materials made to their own with the off-the-shelf specification. Vendors are constantly investing resources in R&D projects based on market trends and the demand for general health management. Key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to enhance sales and profit margins. Strategic M&As continue to be an essential competitive strategy for key players to expand product offerings, access new technology, or increase market share. Vendors also focus on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the IVD raw materials market.

Key Vendors

• Aalto Bio Reagents
• Fapon Biotech
• Fujirebio
• Merck KGaA
• Hoffmann-La Roche
• Thermo Fisher Scientific

Other Prominent Vendors

• ABclonal
• BBI Solutions
• Beijing Diagreat Biotechnology
• Biofootprints Healthcare
• BioPorto
• Creative Diagnostics
• CUSABIO Technology
• EUPROTEIN
• Eximio Biotec
• GenScript ProBio
• Getein Biotech
• Glentham Life Sciences
• HyTest
• ImmunoDiagnostics
• LGC
• Medix Biochemica
• Meridian Bioscience
• More Diagnostics
• MP Biomedicals
• Nanjing Okay Biotechnology
• Nitto Boseki
• OYC Europe
• Prahas Healthcare
• Promega
• ReAgent
• Rockland Immunochemicals
• Sekisui Diagnostics
• SERION Immunologics
• Signalway Antibody
• Suzhou Yacoo Science
• Trina Bioreactives
• Watson International
• Wuhan Huamei Biotech

GEOGRAPHICAL ANALYSIS

In 2021, Europe dominated the global IVD raw materials market compared to other regions. This region is a mature market with developed diagnostic infrastructure available in most countries. The demand for advanced molecular diagnostics in the European countries has gone high owing to the presence of advanced infrastructure in healthcare diagnosis. Point of care diagnostics is the latest trend in the European market. The Europe IVD raw materials market is expected to reach USD 11.80 billion by 2027.

• Geography
• Europe
• Germany
• Italy
• France
• UK
• Spain
• North America
• US
• Canada
• APAC
• China
• Japan
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa